COHERUS BIOSCIENCES INC's ticker is CHRS and the CUSIP is 19249H103. A total of 191 filers reported holding COHERUS BIOSCIENCES INC in Q2 2020. The put-call ratio across all filers is 1.04 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2020 | $296,000 | -44.7% | 18,270 | -38.6% | 0.12% | -21.9% |
Q4 2019 | $535,000 | -65.5% | 29,739 | -61.1% | 0.16% | -72.3% |
Q3 2019 | $1,550,000 | +136.3% | 76,508 | +5.6% | 0.58% | +215.8% |
Q4 2018 | $656,000 | +32.8% | 72,478 | +142.2% | 0.18% | +71.0% |
Q3 2018 | $494,000 | +0.2% | 29,921 | -15.1% | 0.11% | +4.9% |
Q2 2018 | $493,000 | – | 35,233 | – | 0.10% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Atlas Venture Associates IX, LLC | 568,408 | $2,125,846 | 18.08% |
CM Management, LLC | 548,000 | $2,049,520 | 2.18% |
AlphaCentric Advisors LLC | 912,500 | $3,412,750 | 1.94% |
Knott David M Jr | 630,000 | $2,356 | 0.90% |
COURAGE CAPITAL MANAGEMENT LLC | 50,000 | $187 | 0.63% |
Bridge City Capital, LLC | 276,224 | $1,033,078 | 0.52% |
Kohlberg Kravis Roberts & Co. L.P. | 3,036,076 | $11,354,924 | 0.40% |
Ikarian Capital, LLC | 865,787 | $3,238,043 | 0.39% |
Aristotle Capital Boston, LLC | 2,342,977 | $8,762,734 | 0.28% |
TANG CAPITAL MANAGEMENT LLC | 400,000 | $1,496,000 | 0.21% |